MetLife Investment Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,212
| Closed | -$91K | – | 2763 |
|
|
2021
Q4 | $91K | Hold |
7,212
| – | – | ﹤0.01% | 2435 |
|
|
2021
Q3 | $661K | Hold |
7,212
| – | – | 0.01% | 1369 |
|
|
2021
Q2 | $382K | Hold |
7,212
| – | – | ﹤0.01% | 1737 |
|
|
2021
Q1 | $260K | Hold |
7,212
| – | – | ﹤0.01% | 1897 |
|
|
2020
Q4 | $200K | Hold |
7,212
| – | – | ﹤0.01% | 1985 |
|
|
2020
Q3 | $361K | Hold |
7,212
| – | – | ﹤0.01% | 1538 |
|
|
2020
Q2 | $334K | Buy |
7,212
+1,872
| +35% | +$86.7K | ﹤0.01% | 1603 |
|
|
2020
Q1 | $244K | Hold |
5,340
| – | – | ﹤0.01% | 1585 |
|
|
2019
Q4 | $300K | Buy |
+5,340
| New | +$300K | ﹤0.01% | 1749 |
|